Literature DB >> 17521474

Impact of different pH thresholds for 24-hour dual probe pH monitoring in patients with suspected laryngopharyngeal reflux.

O Reichel1, W J Issing.   

Abstract

OBJECTIVES: The gold standard test for laryngopharyngeal reflux is 24-hour pH monitoring, which determines the reflux area index with a pH threshold of less than four (i.e. the reflux area index four). However, refluxed pepsin is able to cause laryngeal injury at pH levels above five. STUDY
DESIGN: Prospective study.
MATERIALS AND METHODS: In order to establish normative values for a reflux area index with a pH threshold of less than five (i.e. the reflux area index five), 29 healthy volunteers underwent pH monitoring. In 45 patients with suspected laryngopharyngeal reflux, reflux area index four and reflux area index five were determined by pH study.
RESULTS: In healthy volunteers, the reflux area index five was 72.6 (95th percentile). In 29 of 44 patients, laryngopharyngeal reflux was diagnosed due to a reflux area index four of greater than 6.3. However, the reflux area index five revealed laryngopharyngeal reflux in six more patients.
CONCLUSIONS: For exact analysis of pH monitoring results, two pH thresholds (less than four and less than five) must be considered. Further studies with a larger number of healthy volunteers are necessary in order to reveal normative values for the reflux area index five parameter.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17521474     DOI: 10.1017/S0022215107008390

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  10 in total

1.  [Diagnosis and therapy of atypical reflux symptoms when PPI therapy fails].

Authors:  M Bajbouj
Journal:  HNO       Date:  2012-03       Impact factor: 1.284

Review 2.  [Laryngopharyngeal reflux and larynx-related symptoms].

Authors:  M Ptok; A Ptok
Journal:  HNO       Date:  2012-03       Impact factor: 1.284

3.  Respiratory and laryngeal symptoms secondary to gastro-oesophageal reflux.

Authors:  G Rafferty; I Mainie; L P A McGarvey
Journal:  Frontline Gastroenterol       Date:  2011-05-04

4.  Does laryngopharyngeal reflux cause intraoral burning sensations? A preliminary study.

Authors:  Sven Becker; Christine Schmidt; Alexander Berghaus; Uta Tschiesner; Bernhard Olzowy; Oliver Reichel
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-02-27       Impact factor: 2.503

5.  The management of periprosthetic leakage in the presence of supra-oesophageal reflux after prosthetic voice rehabilitation.

Authors:  Kai J Lorenz; L Grieser; T Ehrhart; H Maier
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-12-09       Impact factor: 2.503

6.  Halitosis associated volatile sulphur compound levels in patients with laryngopharyngeal reflux.

Authors:  Mehmet Ozgur Avincsal; Aytug Altundag; Seckin Ulusoy; Mehmet Emre Dinc; Abdullah Dalgic; Murat Topak
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-05       Impact factor: 2.503

7.  [Coincidence of fistula enlargement and supra-oesophageal reflux in patients after laryngectomy and prosthetic voice restoration].

Authors:  K J Lorenz; T Ehrhart; L Grieser; H Maier
Journal:  HNO       Date:  2009-12       Impact factor: 1.284

8.  Validation and Reliability of Polish Version of the Reflux Symptoms Index and Reflux Finding Score.

Authors:  Elżbieta Włodarczyk; Tomasz Jetka; Beata Miaśkiewicz; Piotr Henryk Skarzynski; Henryk Skarzynski
Journal:  Healthcare (Basel)       Date:  2022-07-28

9.  Gastroesophageal reflux in bronchiectasis and the effect of anti-reflux treatment.

Authors:  Zhi-Wei Hu; Zhong-Gao Wang; Yu Zhang; Ji-Min Wu; Jian-Jun Liu; Fang-Fang Lu; Guang-Chang Zhu; Wei-Tao Liang
Journal:  BMC Pulm Med       Date:  2013-06-03       Impact factor: 3.317

10.  Extraesophageal Reflux: What Is the Best Parameter for pH-Monitoring Data Analysis from the Perspective of Patient Response to Proton Pump Inhibitors?

Authors:  Karol Zelenik; Petr Matousek; Miroslav Tedla; Jakub Syrovatka; Pavel Kominek
Journal:  Gastroenterol Res Pract       Date:  2013-01-17       Impact factor: 2.260

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.